Related Experiment Video
Updated: Mar 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
β-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect
Ziyu Jiang1, Joe A Jacob2, Dinesh S Loganathachetti3
1Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast UniversityNanjing, China; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese MedicineNanjing, China.
Abstract:
Over the past decade, screening and identifying novel compounds for their biomedical applications has become an upcoming area of research. Identifying the molecular mechanisms of these compounds has become an integral part of anticancer research. β-elemene, a sesquiterpene, is renowned for its anticancer activity against a variety of cell lines. Recent studies on β-elemene have elucidated that it possesses anti-proliferative effect on cancer cells by creating an apoptotic trigger. Interestingly, it also induces protective autophagy in some cancerous cell lines and is less cytotoxic compared to other widely accepted chemotherapeutic agents. This provides an edge with the perception of limited toxicity to normal cells. This mini-review precisely focuses on the studies performed to identify the mechanism of anticancer activity of β-elemene against cancer cells of multiple origin. In accordance to the evaluation made by the studies mentioned, apoptosis has been identified to be most possible reason behind anticancer activity exerted by β-elemene against a variety of cancer cell lines. Cell cycle arrest and necrosis have been credited to be possible alternate mechanisms for the anticancer effect of β-elemene.
Insights
Beta-elemene, a natural compound, shows anticancer effects by triggering apoptosis and potentially causing cell cycle arrest or necrosis in cancer cells. It offers a less toxic alternative to traditional chemotherapy.
Area of Science:
- Natural Product Chemistry
- Molecular Oncology
- Pharmacology
Background:
- Identifying novel anticancer compounds is crucial for biomedical research.
- Beta-elemene, a sesquiterpene, exhibits significant anticancer properties.
- Understanding the molecular mechanisms of beta-elemene is key to its therapeutic application.
Purpose of the Study:
- To review and identify the primary mechanisms of beta-elemene's anticancer activity.
- To consolidate findings on beta-elemene's effects across various cancer cell lines.
- To evaluate the potential of beta-elemene as a chemotherapeutic agent.
Main Methods:
- Literature review of studies investigating beta-elemene's anticancer mechanisms.
- Analysis of research focusing on apoptosis, autophagy, cell cycle arrest, and necrosis induction.
- Comparative assessment of beta-elemene's cytotoxicity against cancer and normal cells.
Main Results:
- Apoptosis induction is the most consistently identified anticancer mechanism of beta-elemene.
- Beta-elemene demonstrates anti-proliferative effects by triggering programmed cell death.
- Protective autophagy and less cytotoxicity compared to conventional agents are notable features.
Conclusions:
- Apoptosis is the principal mechanism underlying beta-elemene's anticancer efficacy.
- Cell cycle arrest and necrosis are potential secondary mechanisms of action.
- Beta-elemene presents a promising, less toxic option for cancer therapy.
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

